Active substance:
- Porcine circovirus type 1, strain cPCV1-2, expressing the ORF2 protein gene of Porcine circovirus type 2a, Inactivated
- Porcine circovirus type 1, strain cPCV1-2b, expressing the ORF2 protein gene of Porcine circovirus type 2b, Inactivated
- Mycoplasma hyopneumoniae, strain P-5722-3, Inactivated
Route of administration:
-
Intramuscular use
Pharmaceutical form:
-
Emulsion for injection
Target species:
-
Pig
Available in:
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Romania
-
Slovakia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)